Feasibility, Safety and Performance Evaluation of an Application Based Training Programme for Patients After a Stroke

Launched by CORINA SCHUSTER-AMFT · Jun 3, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new training program called "TeleRehaStroke," which uses a mobile app called "Blended Clinic." The goal is to see if this app can help patients who have had a stroke during their recovery. Researchers want to find out if the app is easy to use, safe, and effective. Participants in the trial will start using the app during their final weeks in the hospital and will be guided by a therapist. After they leave the hospital, they will continue to use the app for 12 weeks to help with their recovery.

To be part of this trial, participants need to be at least 18 years old and have had a confirmed stroke. They should also be able to read and understand German and own a smartphone or tablet with a good internet connection. However, people with certain conditions that make it hard to follow instructions or join an exercise program will not be eligible. This study is currently recruiting participants, and it aims to support stroke recovery and improve patient experiences during rehabilitation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥18 years
• • Clinically confirmed stroke
• • Modified Rankin Scale score 1-5
• • Able, to read and understand German language
• • Owns a smartphone or a tablet with stable internet connection and the operating system Android version 11 or iOS version 14 or higher
• Exclusion Criteria:
• • Severe Aphasia
• • Clinically significant concomitant disease states: visual, neurological, cardiorespiratory, psychiatric, or orthopaedic limitations that prevent a participant from following the investigator's instructions or limit performance in an exercise programme
• • Recent events such as surgery or other surgical procedures, fractures, which limit the performance in an exercise programme
• • Known or suspected non-compliance, drug or alcohol abuse
• • Participation in another investigation (with interventional therapy, investigational drug or another medical device) within the 30 days preceding and during the present investigation.